Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
AgonOx, Inc.
Vastra Gotaland Region
Vastra Gotaland Region
University of California, San Diego
Case Comprehensive Cancer Center
BioNTech SE
Centre Hospitalier Universitaire Vaudois
University Hospital, Basel, Switzerland
National Cancer Institute (NCI)
Fate Therapeutics
Vastra Gotaland Region
Fate Therapeutics
BGI, China
Karolinska University Hospital
PACT Pharma, Inc.
Genocea Biosciences, Inc.
University Health Network, Toronto
M.D. Anderson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
University of Utah
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center